Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
 QUICK SEARCH:   [advanced]


     


Haematologica, Vol 92, Issue 5, 706-707 doi:10.3324/haematol.10923
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turturro, F.
Right arrow Articles by Welbourne, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turturro, F.
Right arrow Articles by Welbourne, T.

Malignant Lymphomas

ALK-mediated Na+/H+ exchanger-dependent intracellular alkalinization: does it matter for oncogenesis?

Francesco Turturro*,, Michael Driscoll*, Ellen Friday*, Tomas Welbourne°

* Feist-Weiller Cancer Center Department of Medicine
° Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA

Correspondence: Francesco Turturro, LSUHSC, 1501 Kings Highway, Shreveport, LA 71103, USA. Phone: international +1.318.6758863. Fax: international +1.318.6754338. E-mail: fturtu{at}lsuhsc.edu


    ABSTRACT
 TOP
 ABSTRACT
 References
 
In this study we investigated the relevance of the oncogenic protein NPM-ALK in regulating cellular pH (pHi) through the modulation of Na+/H+ exchanger 1 (NHE1)-activity and the consequences of pHi pharmacological manipulation in cells expressing NPM-ALK.

Key words: ALK, ALCL, NHE1, Troglitazone.

We have recently reviewed the biological relevance of ALK and related fusion proteins in oncogenesis.1 A recent study has pointed out that the Na+/H+ exchanger (NHE)1-dependent alkaline pHi is an important event in the malignant-transformation associated phenotype.2 NHE1 is a commonly expressed plasma membrane protein that regulates pHi through an exchange of extracellular Na+ for intracellular H+.3 We have recently shown that troglitazone (TRO) induces prolonged cellular acidosis by inhibiting NHE1 activity and glutamine (GLU) oxidation via the transamination pathway forming alanine (ALA), shifting glutamate (GLU) into ammoniogenesis via oxidative deamination by alanine aminotransferase (ALT), and glutamate dehydrogenase (GDH).4,5 Hence tumor cells express negligible or low levels of GDH. Their dependency upon GLU for rapid growth and proliferation is entirely dependent upon the transamination-pathway.5 To test whether TRO would be effective in arresting proliferation of ALK+/ALCL (anaplastic large cell lymphoma)-derived L82 cells by inducing cellular acidosis and inhibiting GLU oxidation, cells were incubated for 18 h in the presence of 40 µM TRO or vehicle (DMSO), and GLU metabolism and DNA synthesis were determined as previously described.4,5 TRO-treated cells utilized far less GLU (883±789 vs 3190±270 nmoL/mg protein, p<0.05) as a result of marked inhibition (p<0.01) of the pH-dependent transamination reaction (ALA production decreasing from 1293±278 to 218±54 nmol/mg protein). On the other hand, ammonium production equalled GLU utilization consistent with high glutaminase activity of tumor cells, but it failed to increase with TRO (2038±537 vs 3340±637 nmoL/mg for control) reflecting the low activity of GDH in tumor cells. We have previously shown that TRO-induced cellular acidosis (peroxisome proliferator-activated receptor {gamma}(PPAR{gamma})-independent) is associated with reduced DNA synthesis in breast cancer-derived cells.4 As shown in Figure 1A, left side, 3H-thymidine incorporation was decreased in TRO-L82 cells [3252±482 vs L82-control cells 5745±353 (p<0.005)]. We also measured the caspase 3/7 activity since we have recently shown that TRO-induced cellular acidosis is associated with increased mitochondrial permeability.6 L82 cells incubated with 40 µM TRO showed a significant increase of caspase activity measured with CellProbeTMHT Caspase 3/7 Whole Cell Assay, Beckman Coulter, as compared to control at 18 hours (Figure 1A, right side, TRO-L82 cells 6306±134 vs L82-control cells 2063±70, p<0.001). Given the relevance of the consequences of pharmacological manipulation of pHi in ALK+ cells L82, we assessed whether NPM-ALK played any role in regulating the pHi. For this purpose, we stably transfected NIH3T3 fibroblasts with a pSRoMSVtkneo vector expressing NPM-ALK (a gift from Dr. S. Morris, St. Jude Children’s Research Hospital, Memphis, TN, USA) as previously described.7 A striking change in cell morphology was observed in ALK+-NIH3T3 cells that transformed from a single monolayer (controls) to elongated cells with long pseudopodia (Figure 1B, inset). ALK+-NIH3T3 cells proliferated at a faster rate than parental cells, with a 1.5 fold increase in cell number over a period of 72 h (Figure 1B, p<0.02). Ratio of ammonia (NH4) to alanine (ALA) was used as a surrogate marker of pHi as previously described.5 Analysis of the conditioned media from control and ALK+-NIH3T3 cells showed a 4-fold decrease in the ratio of ammonia to ALA (NH4/ALA 16.3 control vs 4.0 for transfectants) consistent with an alkaline pHi and increased proliferation as previously shown.2,5 Subsequently, NHE1 activity was determined as the rate of pHi recovery after an ammonia-chloride (NH4Cl) load and assayed using (2,7)-biscarboxyethyl-5(6)-carboxyfluorescein (BCECF) as previously described.4,5 As shown in Figure 1C, the untransformed NIH3T3 cells (left side) have modest NHE1 activity ({Delta}pH/{Delta}t) compared to the ALK+-NIH3T3 cells (right side) in response to the NH4Cl load as represented by the difference in the recovery phase. Baseline pHi in ALK+-NIH3T3 cells of 7.45 confirmed that as expected these cells were more alkaline than the control at 7.34 (Figure 1C). Our data support a pH-mediated oncogenic activity of NPM-ALK protein through the regulation of the NHE1 activity that favors alkaline conditions by increasing the extrusion of cellular H+. The increased NPM-ALK mediated alkaline conditions favor growth and proliferation that are reversed by TRO-induced cellular acidosis in ALK+-ALCL-derived L82 cells. Our results support the study of drugs that induce cellular acidosis either by interfering with acid extrusion or acid production or, ultimately, by a combination of both in tumors induced by oncogenic alkaline fusion proteins.8


Figure 10920706
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1. A. Left side. [3H]thymidine labeling in ALK+ALCL-derived cells L82. Cells were incubated in fresh media plus 1 µCi/mL [3H]thymidine for 18 hours treated with 40 µM TRO or DMSO (control). Results are shown as count per minute (cpm)/mg. Right side. Caspase 3/7 activity determined as described in the text and represented as RFLUs. B. NIH3T3 cell proliferation is increased by NPM-ALK exogenous expression. Cells after stable transfection and assessed for expression of NPM-ALK (not shown) were plated in 12 well-dish. Proliferation was followed for 72 hours by counting cells by trypan blue exclusion. Conditioned media was collected at all time points and used for metabolic analysis. An inset panel shows the presence of long pseudopodia in ALK+NIH3T3 cells. C. NHE1 exchanger activity is altered by NPM-ALK expression. Cells were plated on specially designed coverslips for exchanger activity measurements. Cells were loaded with pH sensitive dye (BCECF) in Krebs Hensleit Hepes media (KHH). After establishment of baseline pH, cells were pulsed with NH4Cl for 4 mins followed by KHH-recovery time: SR: slow recovery; RR: rapid recovery after acid load.

 


    Footnotes
 
Funding: Feist-Weiller Cancer Center and Louisiana Gene Therapy Consortium Inc. Funds (F. Turturro).


    References
 TOP
 ABSTRACT
 References
 

  1. Pulford K, Morris SW, Turturro F. Anaplastic lymphoma kinase proteins in growth control and cancer. J Cell Physiol 2004;199:330-58.[CrossRef][ISI][Medline]
  2. Reshkin SJ, Bellizzi A, Caldeira S, Albarani V, Malanchi I, Poignee M, et al. Na+/H+ exchanger-dependent intracellular alkalinazation is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J 2000;14:2185-97.[Abstract/Free Full Text]
  3. Cardone RA, Casavola V, Reshkin SJ. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat Rev Cancer 2005;5:786-95.[CrossRef][ISI][Medline]
  4. Turturro F, Friday E, Fowler R, Diya S, Welbourne T. Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferators-activated receptor {gamma}-independent mechanism in breast cancer-derived cell lines. Clin Cancer Res 2005;10:7022-30.[CrossRef][ISI]
  5. Oliver R III, Friday E, Turturro F, Lacy A, Welbourne T. Troglitazone’s rapid and sustained activation of ERK1/2 induces cellular acidosis in LLC-PK1-F+ cells: physiologic responses. Am J Physiol Renal Physiol 2005;288:F1257-66.[Abstract/Free Full Text]
  6. Turturro F, Oliver R, Friday E, Nissim I, Welbourne T. Troglitazone and pioglitazone interactions via PPAR{gamma} independent and dependent pathways in regulating physiological responses in renal tubule derived cell lines. Am J Physiol Cell Physiol 2007;292:C1137-46.[Abstract/Free Full Text]
  7. Kuefer MU, Look AT, Pulford K, Behm FG, Pattengale PK, Mason DY, Morris SW. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 1997;90:2901-10.[Abstract/Free Full Text]
  8. Turturro F, Lawson M, Friday E, Welbourne T. Targeting the Na+/H+ exchanger: an old concept with new perspectives in the treatment of hematological malignancies. Leuk Res 2006;[Epub ahead of print].




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turturro, F.
Right arrow Articles by Welbourne, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turturro, F.
Right arrow Articles by Welbourne, T.


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS